LGALS3 and metabolic dysfunction-associated steatohepatitis: We speculated that galectin-3 deficiency might lead to the higher expression of genes related to the PDGF signaling pathway and consequently accelerate the development of various pathological conditions such as fibrosis and carcinogenesis in patients with NAFLD/NASH.